Navigation Links
Pot Psychosis May Be Gene-Related
Date:11/20/2012

TUESDAY, Nov. 20 (HealthDay News) -- A new study may help explain why some marijuana users develop psychosis. Scientists have pinpointed a gene variant associated with increased risk of mental impairment related to marijuana use.

The growing acceptance of medical and recreational marijuana means more people will be at risk for cannabis-induced psychosis, the researchers noted. They also said there is emerging evidence that marijuana use during adolescence may increase the risk of developing schizophrenia, a serious psychotic disorder.

The study of more than 700 people focused on the AKT1 gene. It's involved in dopamine signaling, which is known to be abnormal in psychosis. Dopamine is a neurotransmitter that plays an important role in mental health.

"We found that cannabis users who carry a particular variant in the AKT1 gene had a twofold increased probability of a psychotic disorder and this increased up to sevenfold if they used cannabis daily," wrote Dr. Marta Di Forti, of King's College London's Institute of Psychiatry in England, and colleagues. "Our findings help to explain why one cannabis user develops psychosis while his friends continue smoking without problems."

Psychosis is typically characterized by marked personality changes, impaired functioning, and a distorted sense of reality.

The findings, published Nov. 15 in the journal Biological Psychiatry, "could also help to design health educational campaigns tailored to reach those young people at particular risk," Di Forti said in a journal news release.

While identification of this gene variant will not lead to the development of a test to assess people's risk for marijuana-related psychosis, it does reveal a genetic factor that could help lead to new treatments for the problem, journal editor Dr. John Krystal noted in the news release.

More information

The U.S. Office of National Drug Control Policy has more about marijuana and mental health.

-- Robert Preidt

SOURCE: Biological Psychiatry, news release, Nov. 14, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. A risk gene for cannabis psychosis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pot Psychosis May Be Gene-Related
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. ... been honored with a 2016 When Work Works Award for its use of effective ... the national When Work Works project administered by the Families and Work Institute (FWI) ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the healthcare ... suppliers for its inaugural Member Conference at the Paris Hotel in Las Vegas, ... operational health of America’s healthcare providers. , The conference was highlighted by the ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
(Date:5/26/2016)... ... ... The Woodlands at John Knox Village , Florida’s first Life Plan ... and healing, celebrated its grand opening, today. The Woodlands at John Knox Village is ... Staff. , “This is an incredibly fulfilling time for John Knox Village as we ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are nearly 14.5 million people living ... survivors worldwide. On Sunday, June 5, 2016, communities around the world will gather to ... , National Cancer Survivors Day® is an annual worldwide Celebration of Life that ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, 2016 ... ; Frankfurt Prime Standard: QIA) today announced that the company ... Diagnostics GmbH to develop and commercialize predictive assays in oncology. ... as a marker to predict effectiveness of anthracycline treatment in ... "We are pleased to partner with Therawis, which developed the ...
(Date:5/25/2016)... May 25, 2016 According to ... Development, Growth and Demand Forecast to 2022 - Industry ... and Others)" published by P&S Market Research, the global ... in 2015, and it is expected to grow at ... the insulin pump segment is expected to witness the ...
Breaking Medicine Technology: